Alternative-care sites: decentralised and employer-based testing
Alternative-care sites, including occupational-health clinics, community health centres, pharmacy-based clinics and employer-sponsored testing services, that buy rapid tests and co
Intelligence / Healthtech & medtech market map / Diagnostics and laboratory products / Point-of-care and ambulatory testing
Rapid diagnostic tests and compact analysers used in physician practices, urgent-care centres, emergency departments and alternative-care sites.
Split by customer type.
Alternative-care sites, including occupational-health clinics, community health centres, pharmacy-based clinics and employer-sponsored testing services, that buy rapid tests and co
Emergency departments that buy rapid diagnostic tests and compact analysers to support immediate triage, treatment initiation and disposition decisions. Excludes central-laboratory
Independent and multi-site physician practices that buy rapid diagnostic tests to triage patients during the visit, support clinical decisions and avoid unnecessary referral or eme
Urgent-care operators that buy rapid tests and compact analysers to triage walk-in patients, rule out time-sensitive conditions and direct patients to the appropriate care pathway.
$18.5B ($13.0B–$24.0B) · 2025 · Bottom-up
Bottom-up: global diagnostic tests market USD 118.6bn (2025) [3][4]. Kits led product type mix [1]; point-of-care kits and compact analysers estimated at ~15% of the global diagnostic tests market, giving ~USD 17.8bn, rounded to USD 18.5bn. Cross-check: North America is 40.0% of clinical diagnostics value [1] and alternative care settings are a stated growth vector [2]. Forecast scaled at the 6.60% market CAGR [3][4] to ~USD 30bn by 2032. Low confidence: no source isolates point-of-care revenue.
// Sell into Point-of-care and ambulatory testing